HealthCare Market Analysis

Global  antidiabetics market  is expected to reach USD 84.13 billion by 2020, according to a new study by Grand View Research, Inc. Growing prevalence of diabetes is the primary driver of this market. Growth in prevalence of disease causing lifestyle disorders such as irregular dietary habits and obesity is also expected to boost product demand by triggering incidence rates of target diseases. Future commercialization of products currently in the pipeline and the presence of large untapped opportunities in the emerging Asia Pacific and Latin American markets is expected to fuel future market growth. Insulin was the most revenue generating segment and its market was valued at over USD 20.0 billion in 2013. Insulin is also one of the most lucrative segments of this market. Introduction of new products exhibiting higher efficacy coupled with the presence of favorable government initiatives are some factors attributing to its market attractiveness Global antidiabetics market, by

The global  burn care market  is expected to reach USD 2.98 billion by 2025, according to a new report by Grand View Research, Inc. Increasing incidence of burn injuries is anticipated to fuel the demand for cost-effective treatment over the forecast period. The introduction of advanced treatment options such as reconstructive surgery and skin graft or bio membrane are expected to upsurge the demand for these products over the coming years. Favorable government initiatives such as reimbursement policies that cover almost 70% to 100% of the treatment cost, upsurge the adoption of advanced wound care products during the forecast period. In addition, government organizations including the World Health Organization (WHO) and nonprofit organizations like the American Burn Association (ABA) are contributing toward raising awareness amongst consumers, which is anticipated to contribute to the growth of the market. For instance, the WHO entered into a collaborative agreement with the

The  anesthesia monitoring devices market  is expected to reach USD 1.9 billion by 2024, according to a new report by Grand View Research, Inc. The growing geriatric population base and the spiraling number of surgeries are anticipated to boost the market growth. Geriatric patients are the target population for this industry as they are highly prone to various chronic disorders and are at a higher risk of developing complications. The rising awareness amongst the physicians about the various factors that affect patient outcomes, such as the choice of anesthetic drug, the appropriate route of administration, and the right dose of the anesthetic agent, as well as the monitoring of the depth of anesthesia is likely to accelerate the growth of the market during the forecast period. Technological advancements in terms of accuracy, portability, and affordability have resulted in the increased usage of these monitoring devices. For instance, the introduction of the new generation, m

The global  poultry diagnostics market  is expected to reach USD 771.4 million by 2025, growing at a CAGR of 9.6%, according to a new report by Grand View Research, Inc. Disease outbreaks, technological advancements, and supportive government initiatives are the key drivers for the substantial growth of poultry diagnostic market. With the outbreak of catastrophic and erosive diseases such as Avian Influenza, Newcastle disease, and other respiratory infections, the farmers are now opting for a preventive diagnosis. These flock-infections are affecting the global trade of layers, broilers, turkeys, and water fowl. As a result, there have been continuous efforts to increase the awareness about these diseases, amongst poultry farmers. Technological advancements in animal health are the key driver and is expected to serve as future growth opportunities. The advent of efficient animal owner’s mobile technology, information management systems and vaccine banks are the key advancements.

The global  mycoplasma testing market  is expected to reach a value of USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc. With growing R&D investments in the field of life sciences, the demand for mycoplasma testing products are anticipated to rise in the near future. Huge opportunities in the life sciences segment are spurring the market growth. Hence, a large amount of investment is being made in the biotechnology and pharmaceutical industries with rising level of healthcare spending across the globe. This is expected to trigger high growth of mycoplasma testing market. Investment in R&D activities by pharmaceutical and biotechnology companies is increasingly being supported by the government. Researches involving drug discovery and development, receive funding from the governmental bodies to a great extent. Moreover, governmental initiatives in the form of awareness campaigns for chronic diseases such as cancer are also encouraging research

The global  genotyping market  is expected to reach USD 37.1 billion by 2024 according to a new report by Grand View Research, Inc. The increasing demand for genotyping tests to evaluate drug efficacy and safety is one of the major drivers for the genotyping market. Genotyping tests are widely used in selecting a highly responsive, patient population subset against a specific drug candidate before initiating clinical trials. The rising need for affordable genotyping services coupled with the high demand for personalized medicines is also expected to propel the market growth.  Major pharmaceutical companies are collaborating with diagnostic manufacturers for the development of novel biomarker-based therapeutics. Significant opportunities for the growth of this market are anticipated due to the above-mentioned collaborative initiatives.  The increasing awareness for prenatal genetic testing pertaining to early detection of chromosomal abnormalities in the high-risk population,

The global  gastrointestinal stents (GI stents) market  is expected to reach USD 472.5 million by 2025, according to a new report by Grand View Research, Inc. Increasing burden of gastrointestinal diseases including biliary diseases, esophageal cancer, and colorectal cancer are anticipated to boost the usage of GI stents across the globe. Individuals above 60 years of age form the key target population for these products, as they are at a high risk of developing gastrointestinal and stomach-related diseases. Thus, aging demographics of most of the economies around the globe is a prime factor driving the growth of the sector. Moreover, reimbursement coverage provided by the Center for Medicare & Medicaid Services (CMS) and various private payers is spurring the adoption of GI stents. U.S. gastrointestinal stents market revenue, by product, 2014 - 2025 (USD Million) Browse full research report on Gastrointestinal Stents Market: http://www.grandviewresearch.com/ind

The global  cell counting market  is expected to reach USD 1.7 billion by 2025, according to a new report by Grand View Research, Inc. Government initiatives working to promote development of cell therapeutics, wherein cell counting plays an imperative role, is expanding growth prospects for the market. As a result of extensive R&D activities, the number of diseases treated with the help of stem cells increased to 82 in 2016 from 27 in 2005. Also, California Institute for Regenerative Medicine’s funding of USD 271 million for stem cell therapy created 12 R&D facilities in California, and these facilities brought approximately USD 543 million funding. In addition, it is also funded by National Institutes of Health (NIH), which approximately invested USD 1,429 million in 2015. Increase in the number of collaborations of research institutes with various public and private entities to promote R&D has provided significant boost to the market. Growing number of proposed gui

The Global  computational biology market  is expected to reach USD 4,285.1 million by 2020 growing at a CAGR of 21.1%, according to a new study by Grand View Research, Inc. Steady increase in the usage & application of computational biology for bioinformatics R&D programs designed for sequencing genomes to better understand biological systems and increasing number of clinical studies in pharmacogenomics and pharmacokinetics for novel drug discovery studies are expected to drive computational biology demand over the next six years. Computational genomics for cellular and biological simulation applications dominated the market in 2013, accounting for over 47% of global revenue. Key factors driving demand for these applications include the growth of drug designing, disease modeling and personalized medicine applications and the growing usage of computational biology for functional and structural genomics, epigenomics and metagenomics for the analysis of protein transcription

The global  superdisintegrants market  is expected to reach USD 487.0 million by 2025, according to a new report by Grand View Research, Inc. Superdisintegrants help in the disintegration of tablet or capsule content into small particles and create a greater surface area for speedy drug release. A number of fast disintegrating tablet such as salbutamol sulphate, and cetirizine hydrochloride in tablet/capsule dosage form for respiratory disorders (bronchitis, asthma, and coughing) are formulated for pediatric and geriatric patients, due to their difficulty or discomfort in swallowing. Superdisintegrant such as crospovidone, croscarmellose sodium, and sodium starch glycolate are used in optimized concentration to formulate such tablets/capsules along with different binders such as MCC and PVP K-30. Browse full research report on Superdisintegrants Market: http://www.grandviewresearch.com/industry-analysis/superdisintegrants-market Further key findings from the study suggest

The global  veterinary reference laboratories (VRL) market  is expected to reach USD 5.13 billion by 2025, according to a new report by Grand View Research, Inc. Increase in incidence of zoonotic diseases is a key driving factor for market growth. Increase in adoption of integrated diagnostic systems coupled with information ecosystems for veterinary diagnostics is anticipated to fuel development. Rise in demand for advanced diagnostic tests and growing awareness amongst consumers are some of the factors expected to boostdemandover the coming years. Moreover, companies are investing in R&D for the advancement of test kits for cost-effective diagnosis & monitoring of animal health, which is expected to boost growth. Some of the advancements in this market include efficient information management systems used in animal diagnostic applications, vaccine banks, and mobile apps for continuous monitoring. High focus toward innovation in veterinary health is anticipated to fuel

The global  surgical drainage devices market  is anticipated to reach USD 2.3 billion by 2025, according to a new report by Grand View Research, Inc. The growth of this market is catapulted by increasing incidence of chronic diseases, the need to curb healthcare expenditure, and additional benefits associated with surgical drain devices. Majority of the times, these devices are used for prevention of fluid accumulation and in postsurgical treatment & care.  With the escalating number of diseases that require surgical intervention, these devices are now being used in hospitals, clinics, and ambulatory surgical centers. Active surgical drain devices make use of negative pressure or vacuum to remove fluid buildup, and are preferred over conventional passive drain devices as they help in healing the wound quickly. Drainage devices are used in cardiothoracic surgeries, neurosurgical procedures, orthopedic surgeries, and abdominal surgeries among others. Global rise in musculo

The global  protein purification and isolation market  is expected to be USD 9.5 billion by 2025, based on a new report by Grand View Research, Inc. Increased funding from both public and private research organizations for research and development of structure-based drugs and technological advancements are key drivers for the market.  Demand is increasing for the development of protein purification products based on single use purification process owing to increased proteomics research and rising need to identify new protein-based ligands with high specificity. Availability of a wide range of novel resins specific for different end users is estimated to be one of the drivers increasing the adoption rate of protein purification techniques. U.S. protein purification & isolation market, by technology, 2014 - 2025 (USD Billion) Browse full research report on Protein Purification & Isolation Market: http://www.grandviewresearch.com/industry-analysis/protein-puri

The global  regenerative medicine market  size is expected to reach USD 5.59 billion by 2025, according to a new report by Grand View Research, Inc. Increased prevalence of neurodegenerative, orthopedic, and other aging-related disorders in geriatric population coupled with rising global geriatric population is anticipated to drive market growth. Developments in biotechnology have enabled gaining in-depth knowledge pertaining to cell division and differentiation as well as the metabolism mechanism of various cells. This enriched knowledge, coupled with emergence of novel streams of biotechnology such as gene therapy and nanotechnology, further prospered use of cell-based technology in therapeutic treatment. Well established regenerative approached for various dermatological indications exists since ages. Technological advances introduced scaffolds, matrices, and grafts engineered for faster regeneration and minimal surgical procedure. Identification of ability of stem cel